Pharma Journalist -

Signet Therapeutics and XtalPi Inc., a physics-based, AI-powered drug R&D company, announced the expansion of their AI drug discovery collaboration to include a new first-in-class…
Read More...

The Medicines Patent Pool (MPP) and Merck, known as MSD outside the United States and Canada, announced the signing of a voluntary licensing agreement to facilitate affordable global…
Read More...

Immunai, a New York-based biotech company, announced a $215M Series B, increasing the company’s total funding to date to $295M. The new capital will be used to expand Immunai’s “drug…
Read More...

Boehringer Ingelheim and Thoeris GmbH announce a collaboration and license agreement with the aim to investigate novel first-in-class therapies for patients with urea cycle disorders…
Read More...

Vertex Pharmaceuticals Incorporated and Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced a new…
Read More...

Teva Pharmaceutical Industries Ltd. and MODAG GmbH announced a strategic collaboration on the exclusive worldwide licensing and development of MODAG's lead compound anle138b and a…
Read More...

Tremeau Pharmaceuticals announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 17/240,446. Once issued, the patent…
Read More...

PTC Therapeutics, Inc. announced that the Brazilian National Health Surveillance Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved the expansion of the indication…
Read More...

Xeris Biopharma Holdings, Inc. a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology,…
Read More...

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo™ (ranibizumab injection) 100 mg/mL for intravitreal use via…
Read More...